Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
PETROCHINA
00857
5
CNOOC
00883
AU Stock MarketDetailed Quotes
Osprey Medical Inc (OSPDA)
- 0.830
- 0.0000.00%
20min DelayNot Open Sep 23 16:00 AET
42.59MMarket Cap-1.04P/E (Static)
0.000High0.000Low0Volume0.000Open0.830Prev Close0.00Turnover0.00052wk High0.00%Turnover Ratio51.32MShares0.00052wk Low0.311EPS TTM7.98MFloat Cap1.110Historical HighLossP/E (Static)9.61MShs Float0.670Historical Low-0.798EPS LYR0.00%Range %--Dividend TTM3.16P/B1Lot Size--Div Yield TTM
Osprey Medical Inc (OSPDA) Income Statement
Quarterly+Annual
YOY
| (FY)Dec 30, 2020 | (FY)Dec 30, 2019 | (FY)Dec 30, 2018 | |
|---|---|---|---|
| Total revenue | -54.38%1.67M | 45.78%3.67M | 2.51M |
| Operating revenue | -54.38%1.67M | 45.78%3.67M | --2.51M |
| Cost of revenue | -30.78%1.22M | 27.71%1.77M | 1.38M |
| Gross profit | -76.38%448.18K | 67.92%1.9M | 1.13M |
| Operating expense | -30.75%14.14M | 5.98%20.42M | 19.26M |
| Selling and administrative expenses | -36.91%9.2M | 8.47%14.57M | --13.44M |
| -Selling and marketing expense | -46.45%5.73M | 7.13%10.7M | --9.99M |
| -General and administrative expense | -10.52%3.46M | 12.37%3.87M | --3.45M |
| Research and development costs | -27.65%2.22M | -15.78%3.06M | --3.64M |
| Depreciation amortization depletion | 8.49%301.68K | 1.51%278.07K | --273.92K |
| -Depreciation and amortization | 8.49%301.68K | 1.51%278.07K | --273.92K |
| Other operating expenses | -3.00%2.43M | 30.47%2.5M | --1.92M |
| Operating profit | 26.07%-13.69M | -2.13%-18.52M | -18.13M |
| Net non-operating interest income (expenses) | |||
| Other net income (expenses) | -90.78%16.04K | -49.49%173.93K | 344.32K |
| Other non-operating income (expenses) | -90.78%16.04K | -49.49%173.93K | --344.32K |
| Income before tax | 25.98%-13.37M | -3.15%-18.07M | -17.51M |
| Income tax | 154.00%5.28K | -239.99%-9.77K | 6.98K |
| Earnings from equity interest net of tax | |||
| Net income | 25.91%-13.38M | -3.05%-18.06M | -17.52M |
| Net income continuous operations | 25.91%-13.38M | -3.05%-18.06M | ---17.52M |
| Noncontrolling interests | |||
| Net income attributable to the company | 25.91%-13.38M | -3.05%-18.06M | -17.52M |
| Preferred stock dividends | |||
| Other under preferred stock dividend | |||
| Net income attributable to common stockholders | 25.91%-13.38M | -3.05%-18.06M | -17.52M |
| Diluted earnings per share | 86.48%-0.565 | 16.40%-4.18 | -5 |
| Basic earnings per share | 86.48%-0.565 | 16.40%-4.18 | -5 |
| Dividend per share | |||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP |
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
The plot took a sharp turn! At a White House cabinet meeting on May 27, Trump publicly expressed dissatisfaction with the negotiations, reje
Futubull Options Sir
May 26 18:03
Options Sir on Macro | Big Week Ahead! US-Iran Deal May Materialize + PCE Data Looms—How to Navigate Markets Next?
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.